New Zealand markets open in 2 hours 59 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
69.99-0.66 (-0.93%)
As of 01:01PM EST. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 587.89B
Enterprise value 3109.84B
Trailing P/E 11.94
Forward P/E 19.90
PEG ratio (5-yr expected) 10.52
Price/sales (ttm)3.23
Price/book (mrq)4.09
Enterprise value/revenue 34.00
Enterprise value/EBITDA 78.93

Trading information

Stock price history

Beta (5Y monthly) 0.36
52-week change 315.59%
S&P500 52-week change 327.11%
52-week high 373.34
52-week low 356.56
50-day moving average 368.16
200-day moving average 367.61

Share statistics

Avg vol (3-month) 36.63M
Avg vol (10-day) 37.4M
Shares outstanding 51.25B
Implied shares outstanding 6N/A
Float 81.25B
% held by insiders 10.10%
% held by institutions 182.35%
Shares short (14 Nov 2021) 423.12M
Short ratio (14 Nov 2021) 43.63
Short % of float (14 Nov 2021) 41.84%
Short % of shares outstanding (14 Nov 2021) 41.84%
Shares short (prior month 14 Oct 2021) 424.01M

Dividends & splits

Forward annual dividend rate 42.84
Forward annual dividend yield 44.04%
Trailing annual dividend rate 32.81
Trailing annual dividend yield 33.98%
5-year average dividend yield 43.42
Payout ratio 447.87%
Dividend date 329 Dec 2021
Ex-dividend date 413 Dec 2021
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 26.91%
Operating margin (ttm)47.25%

Management effectiveness

Return on assets (ttm)12.68%
Return on equity (ttm)37.85%

Income statement

Revenue (ttm)27.48B
Revenue per share (ttm)21.88
Quarterly revenue growth (yoy)12.80%
Gross profit (ttm)21B
Net income avi to common (ttm)7.39B
Diluted EPS (ttm)5.84
Quarterly earnings growth (yoy)620.00%

Balance sheet

Total cash (mrq)6.61B
Total cash per share (mrq)5.27
Total debt (mrq)27.69B
Total debt/equity (mrq)128.95
Current ratio (mrq)1.37
Book value per share (mrq)17.11

Cash flow statement

Operating cash flow (ttm)10.09B
Levered free cash flow (ttm)8.19B